RPMI 8226(人多发性骨髓瘤外周血B淋巴细胞)

https://789.bio/ec/ueD4xD
  • https://789.bio/ec/ueD4xD
  • https://789.bio/ec/me1Vy1
  • https://789.bio/ec/hStLG4
  • https://789.bio/ec/iWyLO4
  • https://789.bio/ec/Rd5hi9
  • https://789.bio/ec/5O4hPO
  • https://789.bio/ec/9x1tyD

货号: CL-0564

Price: ¥2000 ¥2000

Size:
1×10^6Cells/T25 1×10^6Cells/Vial×2Vials

生长培养基: RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]

产品信息

产品名称 RPMI 8226(人多发性骨髓瘤外周血B淋巴细胞)
别称 RPMI 8226; RPMI.8226; RPMI8226; RPMI no 8226; 8226; RPMI 8226/S; RPMI-8226S; RPMI8226/S; 8226/S; Roswell Park Memorial Institute 8226; GM02132; GM2132; GM 2132; Simpson
生长特性 悬浮细胞
细胞形态 淋巴母细胞样
冻存条件 冻存液:55% 基础培养基+40% FBS+5% DMSO
温度:液氮
培养方案A(默认) 生长培养基:RPMI-1640[PM150110]+10% FBS[164210]+1% P/S[PB180120]
培养条件: 气相:空气,95%;CO₂,5%, 温度:37℃
培养方案B(可选) 生长培养基:
培养条件: 气相:, 温度:37℃
推荐传代比例 5-8×10^5 cells/mL
推荐换液频率 2-3次/周
注意事项
  1. 该细胞为悬浮细胞,请注意离心收集细胞悬液;请勿直接倒掉细胞培养液。

参考资料(来源文献)

背景描述 没有证据表明,RPMI 8226细胞能产生重链(细胞质型或分泌型)。
年龄(性别) 61Y Male
组织来源 外周血,B淋巴细胞
细胞类型 肿瘤细胞
肿瘤类型 骨髓瘤细胞
生物安全等级 BSL-1

STR位点信息

STR鉴定图

  • Microenvironment-confined kinetic elucidation and implementation of a DNA nano-phage with a shielded internal computing layer(2025)

    作者:Tang Decui, He Shuoyao, Yang Yani, Zeng Yuqi, Xiong Mengyi, Ding Ding, Wei Weijun, Lyu Yifan, Zhang Xiao-Bing, Tan Weihong

    期刊:Nature Communications

    DOI:10.1038/s41467-025-56219-9

    影响因子:14.7

    引用产品: RPMI 8226 细胞, Jurkat, Clone E6-1 细胞, THP-1 细胞, RPMI-1640 培养基

  • Targeting Senescent Alveolar Epithelial Cells Using Engineered Mesenchymal Stem Cell-Derived Extracellular Vesicles To Treat Pulmonary Fibrosis(2024)

    作者:Yaoying Long, Bianlei Yang, Qian Lei, Fei Gao, Li Chen, Wenlan Chen, Siyi Chen, Wenxiang Ren, Yulin Cao, Liuyue Xu, Di Wu, Jiao Qu, He Li, Yali Yu, Anyuan Zhang, Shan Wang, Weiqun Chen, Hongxiang Wang, Ting Chen, Zhichao Chen, Qiubai Li

    期刊:ACS Nano

    DOI:10.1021/acsnano.3c10547

    影响因子:17.1

    引用产品: A549 [A-549] 细胞, RAW 264.7 细胞, RPMI 8226 细胞

  • NCX1/Ca2+ promotes autophagy and decreases bortezomib activity in multiple myeloma through non-canonical NFκB signaling pathway(2024)

    作者:Li Tingting, Xiao Pingping, Qiu Dongbiao, Yang Apeng, Chen Qingjiao, Lin Junfang, Liu Yao, Chen Junmin, Zeng Zhiyong

    期刊:Cell Communication and Signaling

    DOI:10.1186/s12964-024-01628-4

    影响因子:8.4

    引用产品: KMS-11 细胞, RPMI 8226 细胞

  • Ethanol Extract of Eclipta prostrata induces Multiple Myeloma Ferroptosis via Keap1/Nrf2/HO-1 Axis(2024)

    作者:Wenxia Li, Xuejiao Yin, Hangjie Fu, Jinyuan Liu, Zhiwei Weng, Qingqing Mao, Lijian Zhu, Liuyuan Fang, Zhen Zhang, Bin Din, Hongyan Tong

    期刊:PHYTOMEDICINE

    DOI:10.1016/j.phymed.2024.155401

    影响因子:7.9

    引用产品: RPMI 8226 细胞, U266 [U266B1] 细胞

  • Design and synthesis of triazolopyridine derivatives as potent JAK/HDAC dual inhibitors with broad-spectrum antiproliferative activity(2024)

    作者:Zhengshui Xu, Changchun Ye, Xingjie Wang, Ranran Kong, Zilu Chen, Jing Shi, Xin Chen, Shiyuan Liu

    期刊:JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY

    DOI:10.1080/14756366.2024.2409771

    影响因子:5.6

    引用产品: RPMI 8226 细胞

  • Dimethyl Fumarate Augments Anticancer Activity of ?ngstrom Silver Particles in Myeloma Cells through NRF2 Activation(2024)

    作者:Ben Wu, Zhen-Xing Wang, Hui Xie, Ping-Li Xie

    期刊:Advanced Therapeutics

    DOI:10.1002/adtp.202400363

    影响因子:3.7

    引用产品: U266 [U266B1] 细胞, RPMI 8226 细胞

  • Design, synthesis, and in vitro biological evaluation of novel HDAC inhibitors bearing C-1 phenyl substituted tetrahydroisoquinoline Cap moiety as anti-tumor therapeutic agents(2024)

    作者:Wang Jie, Zhou Chi, Li Bo, Liu Huaqing, Zhang Hui, Liu Lei

    期刊:MEDICINAL CHEMISTRY RESEARCH

    DOI:10.1007/s00044-024-03206-2

    影响因子:2.6

    引用产品: RPMI 8226 细胞

  • Impact of liquid–liquid phase separation- and immune-related gene signatures on multiple myeloma prognosis: focus on DDX21 and EZH2(2024)

    作者:Fengming Wang, Chuyun Shen

    期刊:Hematology

    DOI:10.1080/16078454.2024.2445403

    影响因子:2.0

    引用产品: 人外周血单核细胞, RPMI 8226 细胞, MM.1S 细胞, U266 [U266B1] 细胞

  • LGR4 promotes tumorigenesis by activating TGF-β1/Smad signaling pathway in multiple myeloma(2023)

    作者:Zhigang Yi, Tao Ma, Jia Liu, Wenting Tie, Yanhong Li, Jun Bai, Lijuan Li, Liansheng Zhang

    期刊:CELLULAR SIGNALLING

    DOI:10.1016/j.cellsig.2023.110814

    影响因子:4.8

    引用产品: RPMI 8226 细胞, AMO-1 细胞, U266 [U266B1] 细胞

  • LAMP5 may promote MM progression by activating p38(2023)

    作者:Chen Yan, Ma Tao

    期刊:PATHOLOGY & ONCOLOGY RESEARCH

    DOI:10.3389/pore.2023.1611083

    影响因子:2.8

    引用产品: RPMI 8226 细胞, U266 [U266B1] 细胞, NCI-H929 细胞, AMO-1 细胞

  • Q1:为什么我看的文献里的细胞培养条件和你们官网的培养条件不一样呢?

    部分细胞是会出现多种培养条件的,我们公司优先选择引种来源的培养条件以及建系者所用培养条件,出现差异的原因是不同实验室在保藏过程中更改了细胞的培养条件,为了避免细胞突然更换培养条件后不适应,建议您优先使用厂家推荐的培养条件培养。

识别码示意图

联系我们

400-999-2100

24小时服务热线

sales@procell.com.cn

销售邮箱

×
微信客服 联系我们 返回顶部
在线咨询